[Federal Register Volume 67, Number 150 (Monday, August 5, 2002)]
[Notices]
[Page 50652]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19710]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Heterologous Protection 
Induced by Immunization With Invaplex Vaccine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
10/150,814 entitled ``Heterologous Protection Induced by Immunization 
with Invaplex Vaccine,'' filed May 17, 2002. Foreign rights (PCT/US02/
16029) are also available. The United States Government, as represented 
by the Secretary of the Army has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: In this application is described a 
composition, Invaplex, derived from a gram negative bacteria for use in 
generating an immune response in a subject against one or more 
heterologous species or strains of gram-negative bacteria.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-19710 Filed 8-2-02; 8:45 am]
BILLING CODE 3710-08-M